epigallocatechin gallate has been researched along with Cachexia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Argilés, JM; Barberis, P; Busquets, S; Figueras, M; Fontes de Oliveira, C; López-Soriano, FJ; Olivan, M; Sette, A; Toledo, M; Ventura da Silva, P | 1 |
| Chan, YL; Lai, YJ; Li, TL; Wang, H; Wu, CJ | 1 |
2 other study(ies) available for epigallocatechin gallate and Cachexia
| Article | Year |
|---|---|
Nutraceutical inhibition of muscle proteolysis: a role of diallyl sulphide in the treatment of muscle wasting.
Topics: Allyl Compounds; Animals; Anorexia; Cachexia; Catechin; Cells, Cultured; Dietary Supplements; Genistein; Male; Muscle, Skeletal; Muscular Atrophy; Neoplasms; Rats; Rats, Wistar; Resveratrol; Stilbenes; Sulfides; Weight Loss | 2011 |
Epigallocatechin-3-gallate effectively attenuates skeletal muscle atrophy caused by cancer cachexia.
Topics: Animals; Anticarcinogenic Agents; Blotting, Western; Cachexia; Carcinoma, Lewis Lung; Catechin; Fluorescent Antibody Technique; Male; Mice; Mice, Inbred C57BL; Muscle Proteins; Muscle, Skeletal; Muscular Atrophy; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; SKP Cullin F-Box Protein Ligases; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2011 |